Point72 Hong Kong LTD Zai Lab LTD Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $5,434 - $8,743	-139 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $4,235 - $5,233	139 New	139 $4,000
Q2 2019 Aug 14, 2019	SELL	$25.73 - $35.79 $3,576 - $4,974	-139 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$21.71 - $31.54 $3,017 - $4,384	139 New	139 $4,000
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $2,078 - $3,436	-139 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $2,474 - $3,523	139 New	139 $3,000
Q4 2017 Feb 14, 2018	SELL	$21.23 - $34.09 $112,561 - $180,745	-5,302 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$27.0 - $31.11 $143,154 - $164,945	5,302	5,302 $143,000

125

49.6M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.72B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.